IntrinsicIntrinsic
← Scroll for more →

Financial Statements — ODYY

Balance Sheet

(in millions USD)
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022
Cash & Equivalents0.120.300.620.030.020.000.010.050.000.070.170.200.040.000.040.050.070.270.130.47
Total Current Assets0.150.370.720.140.050.070.110.180.060.150.260.560.410.390.410.820.530.580.290.93
Property, Plant & Equipment--------------------------------0.000.000.000.00
Intangible Assets----------------0.000.000.000.050.050.050.050.050.040.040.04--
Total Non-current Assets*0.000.000.000.000.000.100.160.160.5313.4213.790.050.050.050.050.050.040.040.040.00
Total Assets0.150.370.720.140.050.160.270.340.5913.5814.050.610.460.440.460.870.570.620.330.93
Accounts Payable0.711.481.621.691.621.481.451.461.281.301.271.851.801.911.712.371.551.061.151.37
Short-term Debt--------------------------------1.18------
Total Current Liabilities12.2810.1211.327.307.006.876.736.625.925.705.386.836.616.265.836.255.214.704.513.93
Long-term Debt----------------------------------------
Total Non-current Liabilities*0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Total Liabilities*12.2810.1211.327.307.006.876.736.625.925.705.386.836.616.265.836.255.214.704.513.93
Retained Earnings(68.48)(66.07)(66.83)(63.23)(62.75)(62.49)(62.24)(62.02)(61.00)(48.26)(47.42)(60.64)(60.10)(59.28)(58.00)(56.33)(54.18)(52.17)(49.07)(47.38)
Total Stockholder Equity(12.13)(9.75)(10.60)(7.16)(6.95)(6.70)(6.46)(6.28)(5.33)7.888.67(6.22)(6.16)(5.82)(5.37)(5.38)(4.64)(4.08)(4.18)(3.00)
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022
Total Revenue----------------------------------------
Cost of Revenue----------------------------------------
Gross Profit----------------------------------------
Research & Development--------0.000.000.000.00------0.03------------0.460.32
Selling, General & Admin0.130.300.180.300.260.120.120.520.250.320.440.50(1.97)1.061.311.721.362.801.521.11
Total Operating Expenses----------------------------------------
Operating Income(0.13)(0.30)(0.18)(0.30)(0.15)(0.13)(0.16)(0.58)16.64(0.37)(1.16)(0.85)(0.66)(1.09)(1.49)(2.08)(1.83)(2.87)(1.98)(1.43)
Interest Expense--0.53--------------0.100.140.190.160.190.190.070.180.230.210.22
Net Income(2.41)0.77(3.60)(0.48)(0.25)(0.25)(0.22)(1.02)(12.74)(0.84)13.28(0.54)(0.81)(1.28)(1.67)(2.15)(2.01)(3.10)(1.69)(1.65)
Basic EPS--0.01(0.03)0.00(0.01)0.000.00(0.01)(0.13)(0.01)0.14(0.01)0.00(0.02)(0.02)(0.03)(0.02)(0.04)----
Diluted EPS--0.01(0.03)0.00(0.01)0.000.00(0.01)(0.11)(0.01)0.12(0.01)0.00(0.02)(0.02)(0.03)(0.02)(0.04)----
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Operating Cash Flow(0.16)(0.32)(0.28)(0.28)(0.05)-0.00(0.05)(0.25)(0.06)(0.18)(0.91)(0.06)(0.17)(0.90)(0.28)(0.62)(0.97)(0.42)(1.17)(0.96)
Capital Expenditures----------------------------0.01----------
Free Cash Flow*----------------------------(0.29)----------
Investing Cash Flow--------0.070.000.00--0.000.001.000.000.000.00(0.01)--0.00(0.05)0.000.00
Financing Cash Flow(0.02)0.000.880.29(0.01)0.000.000.300.000.08(0.12)0.220.130.890.270.431.100.131.080.14
← Scroll for more columns →

* Derived from reported values